---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-030236"
form_type: "8-K"
ticker: "HCWB"
cik: "0001828673"
company_name: "HCW Biologics Inc."
filed_at: "2026-06-26T13:00:14+00:00"
generated_at: "2026-06-26T13:01:11.675638+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# HCW Biologics announces 1-for-6 reverse stock split effective June 30, 2026 to maintain Nasdaq listing

## Summary
- Board approved 1-for-6 reverse split; effective 12:01 a.m. ET June 30, 2026; symbol HCWB unchanged.
- Outstanding shares reduce from ~9.58M to ~1.60M; total authorized shares remain 250M.
- Nasdaq Hearings Panel required 20 consecutive trading days >$1.00 by July 29; company met that on June 12.
- Split intended to ensure continued compliance with Bid Price Rule and Panel conditions; CUSIP changes to 40423R303.
- No fractional shares issued; each holder receiving a fractional share instead gets one whole share.

## SEC filing metadata
- accession: 0001493152-26-030236
- form_type: 8-K
- ticker: HCWB
- cik: 0001828673
- company_name: HCW Biologics Inc.
- filed_at: 2026-06-26T13:00:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828673/000149315226030236/0001493152-26-030236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828673/000149315226030236/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-030236
- JSON: https://secwatch.observer/filing/0001493152-26-030236.json
- Plain text: https://secwatch.observer/filing/0001493152-26-030236.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.